Please Wait.....
Report
Cerebrospinal Fluid Management Devices Market Research Report by Product (Shunts, Valve, Critical Care Products, Dural Sealants, Others), by Age Group (Pediatric, Adult, Geriatric), by End User (Hospitals, Ambulatory Settings, Research and Academic Institutes, Others), and by Region (Americas, Europe, Asia-Pacific, Middle East & Africa) Forecast till 2027
Market Report I 2025-08-09 I 142 Pages I Market Research Future
Cerebrospinal Fluid Management Devices Market Research Report by Product (Shunts, Valve, Critical Care Products, Dural Sealants, Others), by Age Group (Pediatric, Adult, Geriatric), by End User (Hospitals, Ambulatory Settings, Research and Academic Institutes, Others), and by Region (Americas, Europe, Asia-Pacific, Middle East & Africa) Forecast till 2027
Market Overview
The global cerebrospinal fluid management devices market is projected to reach USD 3,821.61 million by 2027, growing at a CAGR of 5.45% by the forecast year. Cerebrospinal fluid (CSF) management devices are medical tools designed to regulate and control the flow or drainage of CSF in patients with neurological conditions. They are commonly used in disorders such as hydrocephalus, brain injuries, or tumors to prevent excessive fluid buildup and maintain normal pressure in the brain and spinal cord.
The global cerebrospinal fluid management devices market is being greatly influenced by the rapidly growing geriatric population. The elderly are more susceptible to nervous system diseases, i.e., Alzheimer's disease, Parkinson's disease, and stroke. They are dependent on the supply of advanced treatment. As the UN predicts the number of seniors to increase from 125 million to 425 million in 2050, the rise of age-related disorders will inevitably lead to an increase in hospital visits, subsequently raising the demand for effective CSF solutions that can help in handling the occurrence of complications and improving patient outcomes.
Key Company Development
Natus Medical Incorporated, in October 2017, added more strength to its portfolio via the purchase of the selected neurosurgery business assets of Integra LifeSciences. The transaction encompassed the Camino ICP monitoring product line, the US rights to Integra's fixed pressure shunts, CSF collection systems, Codman's DURAFORM dural graft implant, and standard EVD catheters. This acquisition allowed Natus to enhance its technological capabilities in neurosurgery and reaffirm its commitment to providing the latest solutions. By this step, the company had the possibility to be present in the global cerebrospinal fluid management devices market to a greater extent.
Major Players
Key players in the global cerebrospinal fluid management devices market are Medtronic PLC, Natus Medical Incorporated, B. Braun Melsungen AG, Sophysa, IRRAS AB, Moller Medical GmbH, Argi Grup, Longeviti, Integra LifeSciences, Corporation, and Anuncia.
Report Attribute Details
- Market Size 2019: USD 2,505.13 Million
- Market Size 2027: USD 3,821.61Million
- CAGR (2020-2027): 5.45%
- Base Year: 2019
- Market Forecast Period: 2020-2027
Market Segmentations
- By Product: Shunts - 5.26%, Critical Care Products - 5.44%.
- By Age Group: Pediatric - 5.30%, Adult - 5.67%.
- By End User: Hospitals - 5.41%, Ambulatory Settings - 5.71%.
Regional Insights
The Americas are at the forefront of the global CSF management devices market and have the greatest local strengths of a strong medical device manufacturing base, an advanced healthcare infrastructure, and a high uptake of breakthrough technologies. North America led the market in 2019 with USD 705.99 million, supported by Latin America's contribution of USD 213.13 million.
Europe is the second biggest market after the US, with the growth mainly led by strong R&D investments, positive government initiatives, and a rising awareness of neurological diseases. The likes of Germany, France, and the UK are still going from strength to strength as the main areas of innovation, which is being fostered by the associations between the manufacturers and the neurosurgeons. Europe recorded strong performance, with Western Europe at USD 543.03 million and Eastern Europe at USD 154.80 million.
The Asia-Pacific region is the fastest-growing market, with the rise of healthcare expenditure being the main driver that has also led to an increase in patient awareness and investments in neurological research. The Asia-Pacific market was driven by China (USD 190.98 million), followed by Japan (USD 125.10 million) and India (USD 98.68 million). The formation of the Hydrocephalus Support Association in Australia is compelling, as it unites the research, treatment, and patient support networks, thereby improving the ecosystem.
The Middle East & Africa contribute the least. The region is showing gradual progress, particularly in the GCC. Rising healthcare investments, favorable regulatory reforms, and partnerships between global manufacturers and regional hospitals are opening growth opportunities. Countries such as Saudi Arabia are positioning themselves as medical hubs, enhancing the adoption of advanced neurosurgical technologies.
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY 17
1.1 OVERVIEW 17
1.2 MARKET SYNOPSIS 17
2 MARKET INTRODUCTION 18
2.1 SCOPE OF THE STUDY 18
2.2 RESEARCH OBJECTIVE 18
2.3 LIST OF ASSUMPTIONS 18
3 RESEARCH METHODOLOGY 20
3.1 OVERVIEW 20
3.2 DATA MINING 20
3.3 SECONDARY RESEARCH 21
3.4 PRIMARY RESEARCH 22
3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 22
3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 23
3.5 FORECASTING TECHNIQUES 23
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 24
3.6.1 BOTTOM-UP APPROACH 25
3.6.2 TOP-DOWN APPROACH 25
3.7 DATA TRIANGULATION 26
3.8 VALIDATION 26
4 MARKET DYNAMICS 27
4.1 OVERVIEW 27
4.2 DRIVERS 28
4.2.1 INCREASING PREVALENCE OF HYDROCEPHALUS & SUBSEQUENT RISE IN NUMBER OF SHUNTING PROCEDURES 28
4.2.2 GROWING GERIATRIC POPULATION 28
4.3 RESTRAINT 29
4.3.1 COMPLICATIONS RELATED TO CSF SHUNT SYSTEMS 29
4.4 OPPORTUNITY 29
4.4.1 ENTERING DEVELOPING MARKETS 29
4.5 COVID-19 IMPACT ANALYSIS 30
5 MARKET FACTOR ANALYSIS 31
5.1 VALUE CHAIN ANALYSIS 31
5.1.1 R&D AND DESIGNING 32
5.1.2 MANUFACTURING 32
5.1.3 DISTRIBUTION 32
5.1.4 MARKETING AND SALES 32
5.1.5 POST-SALES MONITORING 32
5.2 PORTER'S FIVE FORCES MODEL 33
5.2.1 THREAT OF NEW ENTRANTS 33
5.2.2 BARGAINING POWER OF SUPPLIERS 34
5.2.3 BARGAINING POWER OF BUYERS 34
5.2.4 THREAT OF SUBSTITUTES 34
5.2.5 INTENSITY OF RIVALRY 34
6 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT 35
6.1 OVERVIEW 35
6.2 SHUNTS 36
6.3 CRITICAL CARE PRODUCTS 38
6.4 DURAL SEALANTS 39
6.5 OTHERS 39
7 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP 40
7.1 OVERVIEW 40
7.2 PEDIATRIC 41
7.3 ADULT 41
7.4 GERIATRIC 42
8 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER 43
8.1 OVERVIEW 43
8.2 HOSPITALS 44
8.3 AMBULATORY SETTINGS 44
8.4 RESEARCH & ACADEMIC INSTITUTES 45
9 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY REGION 46
9.1 OVERVIEW 46
9.2 AMERICAS 48
9.2.1 NORTH AMERICA 51
9.2.1.1 US 54
9.2.1.2 CANADA 56
9.2.2 LATIN AMERICA 59
9.3 EUROPE 62
9.3.1 WESTERN EUROPE 65
9.3.1.1 GERMANY 68
9.3.1.2 FRANCE 71
9.3.1.3 REST OF WESTERN EUROPE 73
9.3.1.4 UK 75
9.3.1.5 ITALY 78
9.3.1.6 SPAIN 80
9.3.2 EASTERN EUROPE 82
9.4 ASIA-PACIFIC 85
9.4.1 CHINA 88
9.4.2 JAPAN 90
9.4.3 REST OF ASIA PACIFIC 93
9.4.4 INDIA 95
9.4.5 SOUTH KOREA 97
9.4.6 AUSTRALIA 100
9.5 MIDDLE EAST & AFRICA 103
9.5.1 MIDDLE EAST 106
9.5.2 AFRICA 108
10 COMPETITIVE LANDSCAPE 111
10.1 OVERVIEW 111
10.2 COMPETITIVE BENCHMARKING 112
10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET 113
10.4 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET 114
10.5 KEY DEVELOPMENT ANALYSIS 114
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 115
10.6.1 ACQUISITION ACTIVITIES 115
10.6.2 EXPANSIONS 115
10.6.3 PRODUCT LAUNCHES 115
10.7 FINANCIAL MATRIX 116
10.7.1 SALES 116
10.7.2 R&D EXPENDITURE 116
11 COMPANY PROFILES 117
11.1 MEDTRONIC PLC 117
11.1.1 COMPANY OVERVIEW 117
11.1.2 FINANCIAL OVERVIEW 118
11.1.3 PRODUCTS/SERVICES OFFERED 118
11.1.4 KEY DEVELOPMENTS 119
11.1.5 SWOT ANALYSIS 119
11.1.6 KEY STRATEGIES 119
11.2 NATUS MEDICAL INCORPORATED 120
11.2.1 COMPANY OVERVIEW 120
11.2.2 FINANCIAL OVERVIEW 120
11.2.3 PRODUCTS/SERVICES OFFERED 121
11.2.4 KEY DEVELOPMENTS 121
11.2.5 SWOT ANALYSIS 122
11.2.6 KEY STRATEGIES 122
11.3 B. BRAUN MELSUNGEN AG 123
11.3.1 COMPANY OVERVIEW 123
11.3.2 FINANCIAL OVERVIEW 123
11.3.3 PRODUCTS/SERVICES OFFERED 124
11.3.4 KEY DEVELOPMENTS 124
11.3.5 SWOT ANALYSIS 125
11.3.6 KEY STRATEGIES 125
11.4 SOPHYSA 126
11.4.1 COMPANY OVERVIEW 126
11.4.2 FINANCIAL OVERVIEW 126
11.4.3 PRODUCTS/SERVICES OFFERED 126
11.4.4 KEY DEVELOPMENTS 126
11.4.5 SWOT ANALYSIS 127
11.4.6 KEY STRATEGIES 127
11.5 IRRAS AB 128
11.5.1 COMPANY OVERVIEW 128
11.5.2 FINANCIAL OVERVIEW 128
11.5.3 PRODUCTS/SERVICES OFFERED 129
11.5.4 KEY DEVELOPMENTS 129
11.5.5 SWOT ANALYSIS 129
11.5.6 KEY STRATEGIES 129
11.6 MOLLER MEDICAL GMBH 130
11.6.1 COMPANY OVERVIEW 130
11.6.2 FINANCIAL OVERVIEW 130
11.6.3 PRODUCTS/SERVICES OFFERED 130
11.6.4 KEY DEVELOPMENTS 130
11.6.5 SWOT ANALYSIS 130
11.6.6 KEY STRATEGIES 131
11.7 ARGI GRUP 132
11.7.1 COMPANY OVERVIEW 132
11.7.2 FINANCIAL OVERVIEW 132
11.7.3 PRODUCTS/SERVICES OFFERED 132
11.7.4 KEY DEVELOPMENTS 132
11.7.5 SWOT ANALYSIS 133
11.7.6 KEY STRATEGIES 133
11.8 LONGEVITI 134
11.8.1 COMPANY OVERVIEW 134
11.8.2 FINANCIAL OVERVIEW 134
11.8.3 PRODUCTS/SERVICES OFFERED 134
11.8.4 KEY DEVELOPMENTS 134
11.8.5 SWOT ANALYSIS 135
11.8.6 KEY STRATEGIES 135
11.9 INTEGRA LIFESCIENCES CORPORATION 136
11.9.1 COMPANY OVERVIEW 136
11.9.2 FINANCIAL OVERVIEW 136
11.9.3 PRODUCTS/SERVICES OFFERED 137
11.9.4 KEY DEVELOPMENTS 137
11.9.5 SWOT ANALYSIS 138
11.9.6 KEY STRATEGIES 138
11.10 ANUNCIA 139
11.10.1 COMPANY OVERVIEW 139
11.10.2 FINANCIAL OVERVIEW 139
11.10.3 PRODUCTS/SERVICES OFFERED 139
11.10.4 KEY DEVELOPMENTS 139
11.10.5 SWOT ANALYSIS 140
11.10.6 KEY STRATEGIES 140
12 APPENDIX 141
12.1 REFERENCES 141
12.2 RELATED REPORTS 141
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS 18
TABLE 2 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT 2017-2027 (USD MILLION) 36
TABLE 3 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS, BY REGION 2017-2027 (USD MILLION) 37
TABLE 4 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 37
TABLE 5 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 37
TABLE 6 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCTS, BY REGION 2017-2027
(USD MILLION) 38
TABLE 7 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCTS, BY TYPE 2017-2027
(USD MILLION) 38
TABLE 8 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027
(USD MILLION) 38
TABLE 9 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR DURAL SEALANTS, BY REGION 2017-2027 (USD MILLION) 39
TABLE 10 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP 2017-2027 (USD MILLION) 41
TABLE 11 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR PEDIATRIC, BY REGION 2017-2027 (USD MILLION) 41
TABLE 12 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR ADULT, BY REGION 2017-2027 (USD MILLION) 42
TABLE 13 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR GERIATRIC, BY REGION 2017-2027 (USD MILLION) 42
TABLE 14 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER 2017-2027 (USD MILLION) 44
TABLE 15 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR HOSPITALS, BY REGION 2017-2027 (USD MILLION) 44
TABLE 16 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR AMBULATORY SETTINGS, BY REGION 2017-2027
(USD MILLION) 45
TABLE 17 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION 2017-2027 (USD MILLION) 45
TABLE 18 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY REGION, 2019 (%) 47
TABLE 19 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY REGION 2017-2027 (USD MILLION) 47
TABLE 20 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY REGION, 2017-2027 (USD MILLION) 48
TABLE 21 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 49
TABLE 22 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 49
TABLE 23 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027
(USD MILLION) 49
TABLE 24 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION) 50
TABLE 25 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027
(USD MILLION) 50
TABLE 26 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 50
TABLE 27 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 51
TABLE 28 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY COUNTRY, 2017-2027 (USD MILLION) 51
TABLE 29 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 52
TABLE 30 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027
(USD MILLION) 52
TABLE 31 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027
(USD MILLION) 52
TABLE 32 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027
(USD MILLION) 53
TABLE 33 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 53
TABLE 34 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 53
TABLE 35 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 54
TABLE 36 US: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 54
TABLE 37 US: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 54
TABLE 38 US: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 55
TABLE 39 US: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION) 55
TABLE 40 US: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027
(USD MILLION) 55
TABLE 41 US: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 56
TABLE 42 US: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 56
TABLE 43 CANADA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 56
TABLE 44 CANADA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 57
TABLE 45 CANADA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027
(USD MILLION) 57
TABLE 46 CANADA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027
(USD MILLION) 57
TABLE 47 CANADA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027
(USD MILLION) 58
TABLE 48 CANADA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 58
TABLE 49 CANADA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 58
TABLE 50 LATIN AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 59
TABLE 51 LATIN AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027
(USD MILLION) 59
TABLE 52 LATIN AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027
(USD MILLION) 59
TABLE 53 LATIN AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION) 60
TABLE 54 LATIN AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 60
TABLE 55 LATIN AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 60
TABLE 56 LATIN AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 61
TABLE 57 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY REGION, 2017-2027 (USD MILLION) 62
TABLE 58 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 63
TABLE 59 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 63
TABLE 60 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 63
TABLE 61 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027
(USD MILLION) 64
TABLE 62 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027
(USD MILLION) 64
TABLE 63 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 64
TABLE 64 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 65
TABLE 65 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY COUNTRY 2017-2027 (USD MILLION) 66
TABLE 66 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 66
TABLE 67 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027
(USD MILLION) 66
TABLE 68 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027
(USD MILLION) 67
TABLE 69 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION) 67
TABLE 70 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE
2017-2027 (USD MILLION) 67
TABLE 71 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 68
TABLE 72 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 68
TABLE 73 GERMANY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 68
TABLE 74 GERMANY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 69
TABLE 75 GERMANY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 69
TABLE 76 GERMANY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027
(USD MILLION) 69
TABLE 77 GERMANY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027
(USD MILLION) 70
TABLE 78 GERMANY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 70
TABLE 79 GERMANY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 70
TABLE 80 FRANCE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 71
TABLE 81 FRANCE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 71
TABLE 82 FRANCE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 71
TABLE 83 FRANCE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027
(USD MILLION) 72
TABLE 84 FRANCE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027
(USD MILLION) 72
TABLE 85 FRANCE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 72
TABLE 86 FRANCE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 73
TABLE 87 REST OF WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 73
TABLE 88 REST OF WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 73
TABLE 89 REST OF WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE
2017-2027 (USD MILLION) 74
TABLE 90 REST OF WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT,
BY TYPE 2017-2027 (USD MILLION) 74
TABLE 91 REST OF WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS,
BY TYPE 2017-2027 (USD MILLION) 74
TABLE 92 REST OF WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 75
TABLE 93 REST OF WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 75
TABLE 94 UK: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 75
TABLE 95 UK: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 76
TABLE 96 UK: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 76
TABLE 97 UK: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027
(USD MILLION) 76
TABLE 98 UK: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027
(USD MILLION) 77
TABLE 99 UK: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 77
TABLE 100 UK: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 77
TABLE 101 ITALY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 78
TABLE 102 ITALY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 78
TABLE 103 ITALY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 78
TABLE 104 ITALY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION) 79
TABLE 105 ITALY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027
(USD MILLION) 79
TABLE 106 ITALY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 79
TABLE 107 ITALY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 80
TABLE 108 SPAIN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 80
TABLE 109 SPAIN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 80
TABLE 110 SPAIN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 81
TABLE 111 SPAIN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027
(USD MILLION) 81
TABLE 112 SPAIN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027
(USD MILLION) 81
TABLE 113 SPAIN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 82
TABLE 114 SPAIN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 82
TABLE 115 EASTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 82
TABLE 116 EASTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027
(USD MILLION) 83
TABLE 117 EASTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027
(USD MILLION) 83
TABLE 118 EASTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION) 83
TABLE 119 EASTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 84
TABLE 120 EASTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 84
TABLE 121 EASTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 84
TABLE 122 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY COUNTRY, 2017-2027 (USD MILLION) 85
TABLE 123 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 86
TABLE 124 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 86
TABLE 125 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027
(USD MILLION) 86
TABLE 126 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027
(USD MILLION) 87
TABLE 127 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 87
TABLE 128 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 87
TABLE 129 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 88
TABLE 130 CHINA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 88
TABLE 131 CHINA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 88
TABLE 132 CHINA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 89
TABLE 133 CHINA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027
(USD MILLION) 89
TABLE 134 CHINA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027
(USD MILLION) 89
TABLE 135 CHINA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 90
TABLE 136 CHINA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 90
TABLE 137 JAPAN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 90
TABLE 138 JAPAN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 91
TABLE 139 JAPAN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 91
TABLE 140 JAPAN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027
(USD MILLION) 91
TABLE 141 JAPAN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027
(USD MILLION) 92
TABLE 142 JAPAN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 92
TABLE 143 JAPAN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 92
TABLE 144 REST OF ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 93
TABLE 145 REST OF ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027
(USD MILLION) 93
TABLE 146 REST OF ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027
(USD MILLION) 93
TABLE 147 REST OF ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION) 94
TABLE 148 REST OF ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 94
TABLE 149 REST OF ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 94
TABLE 150 REST OF ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 95
TABLE 151 INDIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 95
TABLE 152 INDIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 95
TABLE 153 INDIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 96
TABLE 154 INDIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION) 96
TABLE 155 INDIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027
(USD MILLION) 96
TABLE 156 INDIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 97
TABLE 157 INDIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 97
TABLE 158 SOUTH KOREA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 97
TABLE 159 SOUTH KOREA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027
(USD MILLION) 98
TABLE 160 SOUTH KOREA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027
(USD MILLION) 98
TABLE 161 SOUTH KOREA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027
(USD MILLION) 98
TABLE 162 SOUTH KOREA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 99
TABLE 163 SOUTH KOREA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 99
TABLE 164 SOUTH KOREA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 99
TABLE 165 AUSTRALIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 100
TABLE 166 AUSTRALIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 100
TABLE 167 AUSTRALIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 100
TABLE 168 AUSTRALIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027
(USD MILLION) 101
TABLE 169 AUSTRALIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027
(USD MILLION) 101
TABLE 170 AUSTRALIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 101
TABLE 171 AUSTRALIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 102
TABLE 172 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY REGION, 2017-2027 (USD MILLION) 103
TABLE 173 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 104
TABLE 174 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027
(USD MILLION) 104
TABLE 175 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027
(USD MILLION) 104
TABLE 176 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION) 105
TABLE 177 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 105
TABLE 178 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 105
TABLE 179 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 106
TABLE 180 MIDDLE EAST: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 106
TABLE 181 MIDDLE EAST: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 106
TABLE 182 MIDDLE EAST: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027
(USD MILLION) 107
TABLE 183 MIDDLE EAST: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027
(USD MILLION) 107
TABLE 184 MIDDLE EAST: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 107
TABLE 185 MIDDLE EAST: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 108
TABLE 186 MIDDLE EAST: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 108
TABLE 187 AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 108
TABLE 188 AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 109
TABLE 189 AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 109
TABLE 190 AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027
(USD MILLION) 109
TABLE 191 AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027
(USD MILLION) 110
TABLE 192 AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 110
TABLE 193 AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 110
TABLE 194 BENCHMARKING OF MAJOR COMPETITORS 112
TABLE 195 ACTIVE PLAYERS IN THE GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET 114
TABLE 196 ACQUISITION ACTIVITIES 115
TABLE 197 EXPANSIONS 115
TABLE 198 PRODUCT LAUNCHES 115
TABLE 199 MEDTRONIC PLC: PRODUCTS/SERVICES OFFERED 118
TABLE 200 NATUS MEDICAL INCORPORATED: PRODUCTS/SERVICES OFFERED 121
TABLE 201 NATUS MEDICAL INCORPORATED: KEY DEVELOPMENTS 121
TABLE 202 B. BRAUN MELSUNGEN AG: PRODUCTS/SERVICES OFFERED 124
TABLE 203 B. BRAUN MELSUNGEN AG: KEY DEVELOPMENTS 124
TABLE 204 SOPHYSA: PRODUCTS/SERVICES OFFERED 126
TABLE 205 IRRAS AB: PRODUCTS/SERVICES OFFERED 129
TABLE 206 IRRAS AB: KEY DEVELOPMENTS 129
TABLE 207 MOLLER MEDICAL GMBH: PRODUCTS/SERVICES OFFERED 130
TABLE 208 ARGI GRUP: PRODUCTS/SERVICES OFFERED 132
TABLE 209 LONGEVITI: PRODUCTS/SERVICES OFFERED 134
TABLE 210 LONGEVITI: KEY DEVELOPMENTS 134
TABLE 211 INTEGRA LIFESCIENCES CORPORATION: PRODUCTS/SERVICES OFFERED 137
TABLE 212 INTEGRA LIFESCIENCES CORPORATION: KEY DEVELOPMENTS 137
TABLE 213 ANUNCIA: PRODUCTS/SERVICES OFFERED 139
TABLE 214 ANUNCIA: KEY DEVELOPMENTS 139
LIST OF FIGURES
FIGURE 1 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET STRUCTURE 19
FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES 25
FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET 27
FIGURE 4 DRIVER IMPACT ANALYSIS 28
FIGURE 5 RESTRAINT IMPACT ANALYSIS 29
FIGURE 6 VALUE CHAIN ANALYSIS: GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET 31
FIGURE 7 PORTER'S FIVE FORCES ANALYSIS: GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET 33
FIGURE 8 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT 2019 (%) 35
FIGURE 9 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT 2019 & 2027 (USD MILLION) 36
FIGURE 10 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP 2019 (%) 40
FIGURE 11 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP 2019 & 2027 (USD MILLION) 40
FIGURE 12 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER 2019 (%) 43
FIGURE 13 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER 2019 & 2027 (USD MILLION) 43
FIGURE 14 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY REGION 2019 & 2027 (USD MILLION) 46
FIGURE 15 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY REGION 2019 (%) 48
FIGURE 16 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY COUNTRY 2019 (%) 51
FIGURE 17 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY REGION 2019 (%) 62
FIGURE 18 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY COUNTRY 2019 (%) 65
FIGURE 19 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY REGION 2019 (%) 85
FIGURE 20 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY REGION 2019 (%) 103
FIGURE 21 MAJOR MANUFACTURERS IN THE GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, MARKET SHARE (2019) 111
FIGURE 22 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET 113
FIGURE 23 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, COMPETITIVE LANDSCAPE 114
FIGURE 24 SALES 116
FIGURE 25 R&D EXPENDITURE 116
FIGURE 26 MEDTRONIC PLC: FINANCIAL OVERVIEW SNAPSHOT 118
FIGURE 27 MEDTRONIC PLC: SWOT ANALYSIS 119
FIGURE 28 NATUS MEDICAL INCORPORATED: FINANCIAL OVERVIEW SNAPSHOT 120
FIGURE 29 NATUS MEDICAL INCORPORATED: SWOT ANALYSIS 122
FIGURE 30 B. BRAUN MELSUNGEN AG: FINANCIAL OVERVIEW 123
FIGURE 31 B. BRAUN MELSUNGEN AG: SWOT ANALYSIS 125
FIGURE 32 SOPHYSA: SWOT ANALYSIS 127
FIGURE 33 IRRAS AB: FINANCIAL OVERVIEW SNAPSHOT 128
FIGURE 34 IRRAS AB: SWOT ANALYSIS 129
FIGURE 35 MOLLER MEDICAL GMBH: SWOT ANALYSIS 130
FIGURE 36 ARGI GRUP: SWOT ANALYSIS 133
FIGURE 37 LONGEVITI: SWOT ANALYSIS 135
FIGURE 38 INTEGRA LIFESCIENCES CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 136
FIGURE 39 INTEGRA LIFESCIENCES CORPORATION: SWOT ANALYSIS 138
FIGURE 40 ANUNCIA: SWOT ANALYSIS 140
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security